Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary Angioedema. Riedl MA, Yarlas A, Bordone L, Treadwell S, et al. Allergy 2025;80:2361-2368.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Riedl MA, Yarlas A, Bordone L, Treadwell S, et al. Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary Angioedema. Allergy 2025;80:2361-2368.
PMID: 40251904